This NDC is on FDA's drug shortage list (posted Nov 3, 2023)

Reported reason: Other

Product Information

CROMOLYN 100 MG/5 ML ORAL CONC is a generic product labeled by Ritedose Pharmaceuticals, LLC, priced at $0.3694 per ML under NDC 76204002596. Its NADAC has been published 181 times since Sep 28, 2022.

FDA first approved this application on Oct 16, 2017. Its Orange Book therapeutic-equivalence code is AA.

CROMOLYN 100 MG/5 ML ORAL CONC

Cromolyn Sodium Oral Solution (Concentrate)
$0.3694per ML

Strength

100 mg/5mL

NDC

76204002596

Classification

Generic

Dosage Form

SOLUTION, CONCENTRATE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

CROMOLYN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA209264

FDA Approved

10/16/2017

TE Code

AA

On Market Since

12/1/2021

Pharmacological Classes

Decreased Histamine Release
Mast Cell Stabilizer

Price Statistics

The NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has been published 181 times since Sep 28, 2022, and over the history we have for it it has risen 6.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3694 per ML
All-time high$0.4825 (Mar 13, 2024)
All-time low$0.1665 (Nov 20, 2024)
52-week high$0.3694
52-week low$0.3141
Median price$0.3200
Average price$0.3200
Largest weekly change+85.7% (Jan 17, 2024)
Weeks tracked181
Tracking sinceSep 28, 2022

Price History

1W

+0.4%

1M

+5.9%

3M

+10.0%

6M

+9.9%

1Y

+37.1%

3Y

+4.5%

5Y

N/A

All

+6.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Cromolyn Sodium Oral Solution (Concentrate) market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CROMOLYN 100 MG/5 ML ORAL CONC?

The current National Average Drug Acquisition Cost (NADAC) for CROMOLYN 100 MG/5 ML ORAL CONC, manufactured by Ritedose Pharmaceuticals, LLC, is $0.3694 per ML (NDC 76204002596), effective Nov 18, 2026.

How has the price of CROMOLYN 100 MG/5 ML ORAL CONC changed over time?

Over the history we have for it, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has risen 6.1%. It has been tracked across 181 weekly CMS publications since Sep 28, 2022.

What are the highest and lowest recorded NADAC prices for CROMOLYN 100 MG/5 ML ORAL CONC?

Since Sep 28, 2022, the NADAC for CROMOLYN 100 MG/5 ML ORAL CONC has ranged from a low of $0.1665 (Nov 20, 2024) to a high of $0.4825 (Mar 13, 2024), with a median of $0.3200 per ML.

Are there cheaper alternatives to CROMOLYN 100 MG/5 ML ORAL CONC?

No other NADAC-published product currently shares the active ingredient and strength of CROMOLYN 100 MG/5 ML ORAL CONC in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CROMOLYN 100 MG/5 ML ORAL CONC?

CROMOLYN 100 MG/5 ML ORAL CONC (NDC 76204002596) is labeled by Ritedose Pharmaceuticals, LLC, and CMS classifies it as a generic product.

Is CROMOLYN 100 MG/5 ML ORAL CONC in shortage?

Yes — NDC 76204002596 is currently listed in FDA's drug shortage database (posted Nov 3, 2023). Reported reason: Other.